pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 4·1 min read
save

New visa hurdles push foreign PhD scientists to abandon US labs for home-country jobs

May 4, 2026·read at STAT ↗Negative

Recent data show a decline in applications from international students and researchers to U.S. labs, as new immigration procedures create uncertainty.

The article follows a PhD candidate from India who had to pause her research for two months while her visa renewal required public review of her social media, prompting her to abandon a planned postdoc and accept a biotech job back home.

Researchers and institutions report that such intrusive and unpredictable visa requirements are discouraging foreign talent, potentially impacting the U.S. biotech pipeline.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Immigration changes are driving foreign researchers to leave the U.S. — or not come to begin with”

read at STAT ↗
2,249 words · retrieved May 4
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of HealthOVERSEAS
drugs
MIFEPRISTONE
topics
Drug Shortage2NeurologyVaccines

related stories

  • Jun 6Opinion: I led the U.S. CDC response to the 2014 Ebola epidemic. The new outbreak needs massive, immediate, meticulous actionSTAT
  • Sep 25Federal judge rolls back landmark disability protectionsSTAT
  • Sep 22New federal autism committee head has financial ties to leucovorinSTAT
  • Sep 22Lexeo takes up the Mantle in $8M acquisition for Friedreich ataxia assetsFierce Biotech
  • Jul 31Syphilis spreads while researchers contend with federal constraints and a drug shortageSTAT